Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects

Clinical trial NCT00126074 · COMPLETED

Trial details

NCT number: NCT00126074
Sponsor: Solvay Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Atrial Fibrillation Atrial Flutter

Start date: 2004-10-01
Primary completion: 2006-03-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.